Albany, NY, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report, titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023”. According to this report, the global postpartum hemorrhage (PPH) treatment devices market will progress at a 4.90% CAGR during the forecast period from 2015 to 2023. In 2014, the global postpartum hemorrhage treatment devices market was estimated at US$604.4 mn and by 2023, the market is predicted to be worth US$926.1 mn.
The global postpartum hemorrhage (PPH) treatment devices market is driven by the elevated prevalence of PPH. PPH is one of the principal reasons of maternal mortality and accounts for over 30% of all maternal deaths in both developing and developed nations, states the WHO. In addition to this, the global postpartum hemorrhage treatment devices market will benefit from the rising government educational initiatives and training. The growing prevalence of risk factors related to PPH will also fuel the global postpartum hemorrhage treatment devices market. On the contrary, the global postpartum hemorrhage treatment devices market will be suppressed by the lack of product awareness in developing nations and low acceptance rate of unconventional PPH preventive devices.
Request a Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164
Product-wise, the global postpartum hemorrhage (PPH) treatment devices market is segmented into uniject prefilled injection systems, non-pneumatic anti-shock garments (NASG), and uterine balloon tamponades (UBT). Some types of uterine balloon tamponades are condom catheters and Foley catheters. The segment of uterine balloon tamponades held the largest share of 46.3% in the global postpartum hemorrhage treatment devices market in 2014. This segment is projected to continue its dominance in the foreseeable future. Factors driving this segment are the ultra-low cost, high effectiveness, and easy availability of uterine balloon tamponades.
The uterine balloon tamponade (UBT) segment also benefits from the support of various public health organizations. Organizations such as the WHO, the International Confederation of Midwives (ICM), and the American College of Obstetricians and Gynecologists recognize UBTs as a very affordable medical alternative significantly supporting management of PPH in resource-starved places facing a shortage of pharmaceutical and surgical interventions.
Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/postpartum-hemorrhage-treatment-devices-market.htm
By region, the global postpartum hemorrhage (PPH) treatment devices market is classified into North America, Asia Pacific, Europe, Latin America, the Middle East and North Africa, and Rest of the World. North America dominated the global postpartum hemorrhage treatment devices market in 2014. Factors such as the elevated maternal mortality rate due to PPH, enhanced access to health care, increasing incidence of obstetric complications, and availability of medical devices are driving this regional market. Asia Pacific is projected to emerge as the region with the highest growth in the coming few years due to the growing awareness, improving healthcare infrastructure, and high prevalence of PPH and other pregnancy-related complications.
Major Key Players:
Players in the global postpartum hemorrhage (PPH) treatment devices market are increasingly focusing on enhancing their distribution channels and awareness of PPH treatment devices in emerging markets. Some of the key players operating in the global postpartum hemorrhage treatment devices market are Cook Medical, Bactiguard, C.R. Bard, Teleflex Incorporated, Utah Medical Products, and Program for Appropriate Technology in Health (PATH).
Other Industry Reports by TMR:
- Dermatology Diagnostic Devices and Therapeutics Market to Reach US$ 21.1 bn by 2023 as Acute and Chronic Skin Disorders Rise: http://www.transparencymarketresearch.com/dermatology-diagnostic-devices-therapeutics-market.html
- Blood Gas and Electrolyte Analyzer Market to Touch US$3.48 bn by 2023, Demand for Handheld Analyzers Shows Growth: http://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.